NO145438C - Cyklopentanyl-tetrahydropyranyl-eter-derivat for anvendelse ved fremstilling av fysiologisk aktive prostaglandiner - Google Patents

Cyklopentanyl-tetrahydropyranyl-eter-derivat for anvendelse ved fremstilling av fysiologisk aktive prostaglandiner

Info

Publication number
NO145438C
NO145438C NO740849A NO740849A NO145438C NO 145438 C NO145438 C NO 145438C NO 740849 A NO740849 A NO 740849A NO 740849 A NO740849 A NO 740849A NO 145438 C NO145438 C NO 145438C
Authority
NO
Norway
Prior art keywords
prostaglandines
cyclopentanyl
eter
tetrahydropyranyl
derivative
Prior art date
Application number
NO740849A
Other languages
English (en)
Norwegian (no)
Other versions
NO145438B (no
NO740849L (no
Inventor
Michael Ross Johnson
Hans-Jurgen Ernst Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/355,644 external-priority patent/US4094899A/en
Publication of NO740849L publication Critical patent/NO740849L/no
Application filed by Pfizer filed Critical Pfizer
Publication of NO145438B publication Critical patent/NO145438B/no
Publication of NO145438C publication Critical patent/NO145438C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
NO740849A 1972-06-02 1974-03-11 Cyklopentanyl-tetrahydropyranyl-eter-derivat for anvendelse ved fremstilling av fysiologisk aktive prostaglandiner NO145438C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25921572A 1972-06-02 1972-06-02
US05/355,644 US4094899A (en) 1972-06-02 1973-04-30 Oxaprostaglandins

Publications (3)

Publication Number Publication Date
NO740849L NO740849L (no) 1973-12-04
NO145438B NO145438B (no) 1981-12-14
NO145438C true NO145438C (no) 1982-03-24

Family

ID=26947161

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740849A NO145438C (no) 1972-06-02 1974-03-11 Cyklopentanyl-tetrahydropyranyl-eter-derivat for anvendelse ved fremstilling av fysiologisk aktive prostaglandiner

Country Status (19)

Country Link
JP (3) JPS5314062B2 (xx)
AR (2) AR199300A1 (xx)
CA (1) CA1095034A (xx)
CH (3) CH590224A5 (xx)
DD (2) DD124594A5 (xx)
DE (2) DE2327813A1 (xx)
DK (1) DK143498C (xx)
ES (2) ES441003A1 (xx)
FI (1) FI55995C (xx)
GB (3) GB1440603A (xx)
IE (1) IE38568B1 (xx)
IL (2) IL50311A (xx)
IN (1) IN138739B (xx)
LU (1) LU67738A1 (xx)
NL (1) NL162902C (xx)
NO (1) NO145438C (xx)
PH (3) PH11300A (xx)
SE (4) SE415756B (xx)
YU (1) YU36497B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES416865A1 (es) * 1972-07-13 1976-03-01 Pfizer Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15.
WO2021040628A1 (en) 2019-08-28 2021-03-04 Igloocompany Pte. Ltd. System and method for controlling multiple locks

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538120A (en) * 1967-05-22 1970-11-03 Ciba Geigy Corp Cyclopentyl-alkanoic acids
ZA721159B (en) * 1971-03-22 1972-12-27 Ici Ltd Process for the separation of the c-15 epimers of 20-ethyl-9a,11alpha,15-trihydroxy-5-cis-13-trans-prostadienoic acid

Also Published As

Publication number Publication date
JPS4954349A (xx) 1974-05-27
SE7608223L (sv) 1976-07-19
AU5639373A (en) 1974-12-05
DE2344838B2 (de) 1981-04-09
IL50311A (en) 1977-08-31
GB1440603A (en) 1976-06-23
NL162902C (nl) 1980-07-15
IL42373A (en) 1977-08-31
PH11931A (en) 1978-09-13
NL7307740A (xx) 1973-12-04
SE418857B (sv) 1981-06-29
DD109859A5 (xx) 1974-11-20
CA1095034A (en) 1981-02-03
JPS5314062B2 (xx) 1978-05-15
NO145438B (no) 1981-12-14
SE7608222L (sv) 1976-07-19
IN138739B (xx) 1976-03-27
PH12035A (en) 1978-10-16
GB1440602A (en) 1976-06-23
CH586716A5 (xx) 1977-04-15
FI55995B (fi) 1979-07-31
YU146973A (en) 1982-02-25
DE2344838A1 (de) 1973-12-20
DE2344839A1 (de) 1974-02-28
YU36497B (en) 1984-02-29
JPS5239629A (en) 1977-03-28
DK143498B (da) 1981-08-31
LU67738A1 (xx) 1973-12-10
ES441003A1 (es) 1977-03-16
DE2344838C3 (de) 1982-03-18
DK143498C (da) 1982-01-11
AR203386A1 (es) 1975-09-08
IE38568B1 (en) 1978-04-12
NL162902B (nl) 1980-02-15
NO740849L (no) 1973-12-04
PH11300A (en) 1977-11-02
IL42373A0 (en) 1973-07-30
DE2344839B2 (de) 1976-06-24
CH589074A5 (xx) 1977-06-30
DD124594A5 (xx) 1977-03-02
FI55995C (fi) 1979-11-12
AR199300A1 (es) 1974-08-23
SE7608221L (sv) 1976-07-19
SE415756B (sv) 1980-10-27
CH590224A5 (xx) 1977-07-29
JPS5231054A (en) 1977-03-09
DE2327813A1 (de) 1973-12-20
GB1440601A (en) 1976-06-23
ES441002A1 (es) 1977-03-01
IE38568L (en) 1973-12-02
JPS5728706B2 (xx) 1982-06-18

Similar Documents

Publication Publication Date Title
NO140556C (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO793013L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO149139C (no) Dimetyloksofosfonater for anvendelse som utgangsmateriale ved fremstilling av fysiologisk aktive prostaglandiner
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
SE7611316L (sv) Prostansyraderivat och sett for framstellning derav
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
NO138336C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzofuranderivater
NO137825C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolsubstituerte kromonderivater
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
FI54312C (fi) Foerfarande foer framstaellning av tieno-(2,3-d)pyrimidinderivat med avsoendring av urinsyra i urin utoekande
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO143741C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
NO138063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO139050C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
NO145438C (no) Cyklopentanyl-tetrahydropyranyl-eter-derivat for anvendelse ved fremstilling av fysiologisk aktive prostaglandiner
SE400278B (sv) Forfarande for framstellning av fenylketonderivat
SE380805B (sv) Forfarande for framstellning av oxazoler
SE396595B (sv) Forfarande for framstellning av difenylamin och derivat derav
NO141121C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive morfolinderivater
IT978317B (it) Monoazopigmenti e procedimento per la loro preparazione
SE393097B (sv) Forfarande for framstellning av sintermagnesia under tillsettning av zirkoniumforeningar